{"id":58759,"date":"2024-02-28T05:27:04","date_gmt":"2024-02-28T05:27:04","guid":{"rendered":"https:\/\/medsname.com\/admenta\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"admenta","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/admenta\/","title":{"rendered":"Admenta"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Admenta?<\/h3>\n<p style=\"margin:0;\"><strong>Admenta<\/strong> je peror\u00e1ln\u00ed tableta od Sun Pharma obsahuj\u00edc\u00ed <strong>memantine 5 mg<\/strong> \u2014 jeden <strong>uncompetitive NMDA receptor antagonist<\/strong> used for the symptomatic treatment of <strong>moderate-to-severe Alzheimer&#39;s disease<\/strong>. Memantine is <strong>ne<\/strong> indicated for mild Alzheimer&#39;s. Slow upward titration over 4 weeks: <strong>5 mg week 1, 10 mg week 2 (5 mg twice daily), 15 mg week 3, 20 mg week 4 onwards (10 mg twice daily)<\/strong>. Generally well tolerated &mdash; main side effects are dizziness, headache, constipation and confusion. <strong>Reduce dose if eGFR &lt; 30 mL\/min<\/strong>. Often combined with donepezil in moderate-to-severe disease for additive cognitive benefit.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">What Is Admenta?<\/h2>\n<p>Admenta is an oral tablet from Sun Pharma containing <strong>memantine hydrochloride 5 mg<\/strong>. Memantine is a low-affinity, voltage-dependent, uncompetitive antagonist of the <strong>N-methyl-D-aspartate (NMDA) glutamate receptor<\/strong>. It is mechanistically distinct from the cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and works through the second major pathway implicated in Alzheimer&#39;s disease &mdash; glutamate excitotoxicity.<\/p>\n<p>Admenta from Sun Pharma is a 5 mg memantine tablet &mdash; the strength used during the mandatory 4-week up-titration to the 20 mg\/day maintenance dose. Maintenance dosing is two 5 mg tablets twice daily (4 tablets total per day). Memantine is licensed only for <strong>moderate-to-severe Alzheimer&#39;s disease<\/strong> &mdash; not mild. It is the standard add-on to a cholinesterase inhibitor (typically donepezil) when patients progress past the mild stage, and produces additive cognitive and functional benefit with minimal increase in side effects.<\/p>\n<h2 class=\"wp-block-heading\">How Does Admenta Work?<\/h2>\n<p>Alzheimer&#39;s disease causes chronic excessive glutamate signalling at NMDA receptors &mdash; a process called <strong>glutamate excitotoxicity<\/strong>. Constant low-level NMDA activation damages neurons and disrupts the signal-to-noise ratio that the brain needs for learning and memory. Memantine addresses this through a unique mechanism:<\/p>\n<ul>\n<li><strong>Voltage-dependent NMDA blockade<\/strong> &mdash; memantine binds to NMDA receptor channels but only when they are already open. It blocks chronic low-level excitotoxic activation but releases the receptor during high-amplitude physiological signalling needed for learning. This is the key difference between memantine and older NMDA blockers like ketamine, which block both modes and cause cognitive impairment.<\/li>\n<li><strong>Restores signal-to-noise ratio<\/strong> &mdash; by reducing background glutamate noise, memantine improves the brain&#39;s ability to detect meaningful signals during learning and memory tasks.<\/li>\n<li><strong>Neuroprotective effect<\/strong> &mdash; reduced excitotoxicity may slow the progression of neuronal damage, though this has not been definitively shown to translate into a clinically meaningful disease-modifying effect.<\/li>\n<\/ul>\n<p>N\u00e1stup kognitivn\u00edho p\u0159\u00ednosu: viditeln\u00fd p\u0159i <strong>4&ndash;12 weeks<\/strong> after reaching the maintenance 20 mg\/day dose; peak benefit at 6 months.<\/p>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>Moderate-to-severe Alzheimer&#39;s dementia<\/strong> &mdash; first-line indication<\/li>\n<li><strong>Combination therapy with a cholinesterase inhibitor<\/strong> &mdash; standard of care in moderate-to-severe Alzheimer&#39;s; additive cognitive benefit<\/li>\n<li><strong>Vaskul\u00e1rn\u00ed demence (sm\u00ed\u0161en\u00fd typ)<\/strong> \u2014 mimor\u00e1mcov\u00fd m\u00edrn\u00fd p\u0159\u00ednos<\/li>\n<li><strong>Dementia with Lewy bodies<\/strong> &mdash; off-label, useful for behavioural symptoms<\/li>\n<\/ul>\n<p>Admenta is <strong>ne<\/strong> indikov\u00e1n pro: <strong>mild Alzheimer&#39;s disease<\/strong> (cholinesterase inhibitors are first-line at this stage), mild cognitive impairment without dementia, frontotemporal dementia, or as a cognitive enhancer in healthy adults.<\/p>\n<h2 class=\"wp-block-heading\">Admenta Dosage and How to Take &mdash; SLOW TITRATION<\/h2>\n<p>Admenta comes at <strong>5 mg<\/strong> tablets. The titration schedule is mandatory &mdash; jumping straight to 20 mg\/day causes intolerable confusion and dizziness in most patients.<\/p>\n<p><strong>Standard 4-week titration:<\/strong><\/p>\n<ul>\n<li><strong>Week 1:<\/strong> 5 mg once daily (1 tablet morning)<\/li>\n<li><strong>Week 2:<\/strong> 10 mg\/day = 5 mg twice daily (morning + evening)<\/li>\n<li><strong>Week 3:<\/strong> 15 mg\/day = 10 mg morning + 5 mg evening<\/li>\n<li><strong>Week 4 onward (maintenance):<\/strong> 20 mg\/day = 10 mg twice daily<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">How to Take Admenta Properly<\/h3>\n<ol>\n<li><strong>U\u017e\u00edvejte s j\u00eddlem nebo nala\u010dno<\/strong> &mdash; food does not affect absorption.<\/li>\n<li><strong>Polykejte cel\u00e9 s vodou.<\/strong> Standard tablets can be split if scored.<\/li>\n<li><strong>Twice daily at maintenance dose<\/strong> (10 mg morning + 10 mg evening), spaced about 12 hours apart.<\/li>\n<li><strong>\u00daprava d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed:<\/strong> if estimated GFR is 30&ndash;49 mL\/min, cap maintenance dose at 10 mg\/day. If eGFR is 5&ndash;29 mL\/min, maintenance dose is 10 mg\/day. Avoid in eGFR &lt; 5 mL\/min.<\/li>\n<li><strong>Vynechan\u00e1 d\u00e1vka:<\/strong> if remembered the same day, take it. If remembered the next day, skip and resume normally &mdash; do not double-dose.<\/li>\n<li><strong>If treatment is interrupted for more than a few days<\/strong>, restart at 5 mg\/day and re-titrate over 4 weeks. Memantine has no acute discontinuation syndrome but the slow titration is needed to avoid side effects.<\/li>\n<li><strong>Caregiver supervision is critical<\/strong> &mdash; patients with moderate-severe Alzheimer&#39;s rarely manage twice-daily dosing reliably without support. Use a weekly pill organiser filled by a family member or carer.<\/li>\n<li><strong>Znovu vyhodno\u0165te po 6 m\u011bs\u00edc\u00edch<\/strong> with formal cognitive testing (MMSE or MoCA). Continue if there is benefit or stabilisation; stop gradually if clear deterioration despite full-dose treatment.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Admenta<\/h2>\n<p><strong>Common (worst during titration, settle once on maintenance):<\/strong><\/p>\n<ul>\n<li>Z\u00e1vrat\u011b<\/li>\n<li>Bolest hlavy<\/li>\n<li>Confusion or worsening confusion (often improves once on stable maintenance dose)<\/li>\n<li>Z\u00e1cpa<\/li>\n<li>Sleepiness or fatigue<\/li>\n<li>Hypertension (mild rise in BP)<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9:<\/strong><\/p>\n<ul>\n<li>Hallucinations or worsening of existing hallucinations<\/li>\n<li>Agitation or aggression (paradoxical, especially during titration)<\/li>\n<li>Falls (from dizziness)<\/li>\n<li>Urinary tract infections<\/li>\n<\/ul>\n<p><strong>Rare but seek medical review:<\/strong><\/p>\n<ul>\n<li>K\u0159e\u010de<\/li>\n<li>Severe psychiatric symptoms (psychosis, mania)<\/li>\n<li>Pankreatitida<\/li>\n<li>Hepatitida<\/li>\n<li>Stevens-Johnson syndrome (case reports)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>Porucha funkce ledvin:<\/strong> dose reduction is mandatory. Cap at 10 mg\/day if eGFR 5&ndash;49 mL\/min. Avoid if eGFR &lt; 5 mL\/min. Memantine accumulates in renal failure and causes toxicity.<\/li>\n<li><strong>Urinary alkalisation:<\/strong> conditions that raise urine pH (severe UTI, renal tubular acidosis, vegetarian diet with high-dose alkalinising drugs, sodium bicarbonate) reduce memantine clearance and raise blood levels &mdash; monitor for side effects.<\/li>\n<li><strong>Historie z\u00e1chvat\u016f:<\/strong> use cautiously &mdash; memantine may lower seizure threshold.<\/li>\n<li><strong>Recent myocardial infarction, uncontrolled hypertension, severe heart failure:<\/strong> caution &mdash; not enough safety data in these populations.<\/li>\n<li><strong>Porucha funkce jater:<\/strong> no dose adjustment for mild-moderate; caution in severe.<\/li>\n<li><strong>Hallucinations and delusions:<\/strong> can worsen pre-existing psychiatric symptoms in some patients with dementia. Monitor for behavioural changes.<\/li>\n<li><strong>Podpora pe\u010dovatele:<\/strong> patients in the moderate-severe Alzheimer&#39;s population for whom memantine is indicated rarely manage their own medication. Caregiver involvement in dose preparation, supervision and adherence is essential.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindications &mdash; Who Should NOT Take Admenta<\/h2>\n<ul>\n<li>Known hypersensitivity to memantine or any tablet excipient<\/li>\n<li>Severe renal impairment (eGFR &lt; 5 mL\/min)<\/li>\n<li>Mild Alzheimer&#39;s dementia (use a cholinesterase inhibitor first)<\/li>\n<li>Mild cognitive impairment without dementia<\/li>\n<li>Frontotemporal dementia (no benefit and may worsen behavioural symptoms)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kombinujte s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Other NMDA antagonists (amantadine, ketamine, dextromethorphan)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Additive psychotomimetic effects (confusion, hallucinations, dissociation)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid combination. Tell anaesthetist about memantine before any procedure involving ketamine.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cholinesterase inhibitors (donepezil, galantamine, rivastigmine)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard combination &mdash; additive cognitive benefit, no significant interaction<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard add-on therapy in moderate-severe Alzheimer&#39;s. See <a href=\"https:\/\/medsbase.com\/cs\/aricep\/\">Aricep<\/a>.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hydrochlorothiazide and other thiazide diuretics<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Memantine reduces diuretic effect; thiazide raises memantine levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor BP and check for memantine side effects.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sodium bicarbonate, acetazolamide, urinary alkalisers<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce renal clearance of memantine &mdash; raise blood levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor for memantine toxicity (confusion, dizziness, sleepiness).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Levodopa, dopamine agonists (Parkinson&#39;s drugs)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Memantine may potentiate dopaminergic effects<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor for dyskinesias and psychiatric side effects.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Barbiturates, neuroleptics (antipsychotics)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Memantine may reduce their effect<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor symptom control; titrate as needed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Some case reports of raised INR with combination<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Check INR more frequently after starting memantine.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i pokojov\u00e9 teplot\u011b, <strong>15\u201325\u00b0C<\/strong>. Chra\u0148te p\u0159ed sv\u011btlem a vlhkost\u00ed.<\/li>\n<li>Tablety uchov\u00e1vejte v p\u016fvodn\u00edm blistru a\u017e do pou\u017eit\u00ed.<\/li>\n<li>Neskladujte v koupeln\u011b \u2013 vlhkost zkracuje trvanlivost.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed a pacient\u016f, kte\u0159\u00ed nemus\u00ed ch\u00e1pat, \u017ee se jedn\u00e1 o l\u00e9ky.<\/li>\n<li>Nepou\u017e\u00edvejte po uplynut\u00ed data expirace uveden\u00e9ho na obalu.<\/li>\n<li>Nepou\u017eit\u00e9 tablety vra\u0165te do l\u00e9k\u00e1rny k likvidaci.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<p>Dal\u0161\u00ed l\u00e9ky na Alzheimerovu chorobu a demenci skladem na MedsBase:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aricep\/\"><strong>Aricep (donepezil 5 \/ 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/donect\/\"><strong>Donect (donepezil 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/donemax\/\"><strong>Donemax (donepezil 10 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/galamer\/\"><strong>Galamer (galantamine 4 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/rivamer-2\/\"><strong>Rivamer (rivastigmin 1,5 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p>U\u017eite\u010dn\u00e9 \u010dten\u00ed: <a href=\"https:\/\/medsbase.com\/cs\/everything-you-need-to-know-about-alzheimers-disease\/\">V\u0161e, co pot\u0159ebujete v\u011bd\u011bt o Alzheimerov\u011b chorob\u011b<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/cs\/everything-to-know-about-dementia\/\">V\u0161e, co pot\u0159ebujete v\u011bd\u011bt o demenci<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/cs\/7-ways-to-protect-your-brain-health-as-you-age\/\">7 zp\u016fsob\u016f, jak chr\u00e1nit zdrav\u00ed sv\u00e9ho mozku s p\u0159ib\u00fdvaj\u00edc\u00edm v\u011bkem<\/a> \u00b7 <a href=\"https:\/\/medsbase.com\/cs\/best-foods-for-a-healthy-brain-and-improved-memory\/\">Nejlep\u0161\u00ed potraviny pro zdrav\u00fd mozek a lep\u0161\u00ed pam\u011b\u0165<\/a>.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Why is Admenta only for moderate-to-severe Alzheimer&#39;s?<\/h3>\n<p>Trials show no clinically meaningful cognitive benefit from memantine in mild Alzheimer&#39;s &mdash; the glutamate excitotoxicity pathway becomes a dominant driver of symptoms only later in the disease. For mild Alzheimer&#39;s, a cholinesterase inhibitor (donepezil, galantamine, rivastigmine) is first-line. Memantine is added when the patient progresses to moderate or severe disease.<\/p>\n<h3 class=\"wp-block-heading\">Can Admenta be combined with donepezil?<\/h3>\n<p>Yes &mdash; this is the standard combination for <strong>moderate-to-severe Alzheimer&#39;s disease<\/strong>. The two drugs work on different pathways (cholinergic + glutamatergic) and produce additive cognitive and functional benefit. There is no significant pharmacokinetic interaction. Combination therapy is more effective than either drug alone at the moderate-to-severe stage. <a href=\"https:\/\/medsbase.com\/cs\/aricep\/\">Aricep (donepezil)<\/a> je standardn\u00ed kombinac\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Why does Admenta need a 4-week titration?<\/h3>\n<p>Jumping to the 20 mg\/day maintenance dose on day one causes intolerable confusion, dizziness and sometimes hallucinations &mdash; bad enough that most patients discontinue. The 4-week up-titration (5 &rarr; 10 &rarr; 15 &rarr; 20 mg\/day) lets the brain adapt to NMDA blockade gradually. Skipping titration is the most common reason patients &ldquo;cannot tolerate&rdquo; memantine.<\/p>\n<h3 class=\"wp-block-heading\">When will I or my family member see results?<\/h3>\n<p>Viditeln\u00e9 zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed se objevuje <strong>4&ndash;12 weeks<\/strong> after reaching the 20 mg\/day maintenance dose; peak benefit at 6 months. Like donepezil, memantine is symptomatic therapy, not disease-modifying. Re-assess with formal cognitive testing at 6 months.<\/p>\n<h3 class=\"wp-block-heading\">Does Admenta need dose adjustment for kidney problems?<\/h3>\n<p>Yes. Memantine is renally cleared and accumulates in kidney impairment. Dose caps: <strong>eGFR 30&ndash;49 mL\/min<\/strong> &mdash; cap maintenance at 10 mg\/day. <strong>eGFR 5&ndash;29 mL\/min<\/strong> &mdash; maintenance 10 mg\/day. <strong>eGFR &lt; 5 mL\/min<\/strong> &mdash; avoid memantine entirely. Check kidney function before starting and at any sign of toxicity (confusion, sleepiness, dizziness on a previously stable dose).<\/p>\n<h3 class=\"wp-block-heading\">Is Admenta a cure or does it slow Alzheimer&#39;s progression?<\/h3>\n<p><strong>Neither.<\/strong> Memantine is symptomatic therapy &mdash; it stabilises function for a window of typically 6&ndash;18 months. The underlying neurodegeneration continues. Newer disease-modifying drugs (anti-amyloid antibodies like lecanemab and donanemab) target the underlying pathology but require IV infusion, regular MRI monitoring, and specialist supervision &mdash; they are not stocked here.<\/p>\n<h3 class=\"wp-block-heading\">Does Admenta help with behavioural symptoms (agitation, aggression, hallucinations)?<\/h3>\n<p>Modest benefit on agitation and aggression in moderate-severe Alzheimer&#39;s &mdash; one of the reasons memantine is the preferred add-on at this stage rather than a second cholinesterase inhibitor. Memantine can paradoxically worsen hallucinations in a minority of patients &mdash; monitor and stop if this occurs.<\/p>\n<h3 class=\"wp-block-heading\">Can I stop Admenta if it is not helping?<\/h3>\n<p>Discuss with the prescriber. If formal cognitive testing at 6 months shows no benefit and the patient has progressed clearly, memantine can be stopped. Unlike donepezil, memantine has no significant discontinuation syndrome &mdash; but a gradual taper over 1&ndash;2 weeks is still standard practice.<\/p>\n<h3 class=\"wp-block-heading\">Is Admenta safe with my parent&#39;s blood pressure or heart medications?<\/h3>\n<p>Memantine is generally safe with most cardiovascular medications. There is no significant interaction with beta-blockers, ACE inhibitors, ARBs, calcium channel blockers, statins, or aspirin. Thiazide diuretics may slightly raise memantine levels &mdash; monitor for side effects but no dose adjustment is usually needed. Memantine causes a mild rise in BP in some patients &mdash; check BP at the 6-week and 3-month visits.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/duovir-n\/\">Duovir N<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/neomercazole\/\">Neomercazole<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/venish-sr\/\">Venish SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/syndopa\/\">Syndopa<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/pregastar\/\">Pregastar 75 mg (Pregabalin) \u2014 Neuropathic Pain &amp; Anxiety<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Enhances cognition<br \/>\n\u2705 Improves memory<br \/>\n\u2705 Slows neurodegeneration<br \/>\n\u2705 Reduces confusion<br \/>\n\u2705 Manages Alzheimer&#8217;s<\/p>\n<p>Admenta contains Memantine.<\/p>","protected":false},"featured_media":58760,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3772,3141,3223],"product_tag":[4562,4563],"class_list":{"0":"post-58759","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-alzheimers-treatment","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-admenta","10":"product_tag-memantine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/58759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=58759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/58760"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=58759"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=58759"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=58759"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=58759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}